TY  - GEN
AU  - Pratz,K W
AU  - Cho,E
AU  - Levis,M J
AU  - Karp,J E
AU  - Gore,S D
AU  - McDevitt,M
AU  - Stine,A
AU  - Zhao,M
AU  - Baker,S D
AU  - Carducci,M A
AU  - Wright,J J
AU  - Rudek,M A
AU  - Smith,B D
TI  - A pharmacodynamic study of sorafenib in patients with relapsed and refractory acute leukemias
SN  - 1476-5551
PY  - 2010///0914
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - pharmacokinetics
KW  - Benzenesulfonates
KW  - Extracellular Signal-Regulated MAP Kinases
KW  - antagonists & inhibitors
KW  - Female
KW  - Humans
KW  - Leukemia, Myeloid, Acute
KW  - blood
KW  - Male
KW  - Middle Aged
KW  - Niacinamide
KW  - analogs & derivatives
KW  - Phenylurea Compounds
KW  - Precursor Cell Lymphoblastic Leukemia-Lymphoma
KW  - Protein Kinase Inhibitors
KW  - Pyridines
KW  - Recurrence
KW  - Sorafenib
KW  - fms-Like Tyrosine Kinase 3
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/leu.2010.132
ER  -